Drug Profile
Lamivudine/tenofovir disoproxil fumarate - Sun Pharmaceutical Industries
Alternative Names: Tenofovir disoproxil fumarate/lamivudine - Sun Pharmaceutical IndustriesLatest Information Update: 06 Dec 2018
Price :
$50
*
At a glance
- Originator Ranbaxy Laboratories
- Developer Ranbaxy Laboratories; Sun Pharmaceutical Industries
- Class Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Phosphonic acids; Purines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV infections